Cancer Clinical Trial
Official title:
Integrating an Occupational Therapy Health and Wellness Program (OT-HAWP) Into an Existing Cancer Support Community
The number of cancer survivors today is growing exponentially and many survivors have unmet
needs due to the late side effects of treatment. The purpose of this study is to explore the
impact that a four-week Occupational Therapy Health and Wellness Program has on perceived
satisfaction and performance of daily activities, fatigue, sleep quality, and health-related
quality of life among adult community-dwelling cancer survivors.
Eligibility criteria for prospective participants includes cancer survivors with a past or
present diagnosis that are at least 18 years old, able to consent, are English speaking, are
able to fill out demographic information as well as pretest/posttest questionnaires, have
indicated concerns within performance of daily activities and are able and willing to
participate in a four-week Occupational Therapy Health and Wellness Program.
This quantitative study will use a prospective, one-group pretest-posttest design to explore
the effects of a four-week Occupational Therapy Health and Wellness Program. Data that will
be collected to track changes include physical, mental, and social health (measured by PROMIS
questionnaire); fatigue levels (measured by the MAF questionnaire); Sleep quality (measured
by the PSQI questionnaire); and self-perceived occupational performance and satisfaction
(measured by the COPM interview/questionnaire) of community-dwelling cancer survivors.
Descriptive statistics will be used to compare pretest/posttest scores. Matched pairs t-test
and Wilcoxin signed ranks test will be used if data is normally distributed. Normality will
be tested by Shapiro wilks test and all data will be analyzed using t-tailed tests with
significance set at .05.
The purpose of this study is to explore the impact that a four-week Occupational Therapy (OT)
Health and Wellness Program has on perceived satisfaction and performance of daily
activities, fatigue, sleep quality, and health-related quality of life among adult
community-dwelling cancer survivors.
The research questions for this study are as follows:
1. What changes occur in community-dwelling cancer survivors in Physical, Mental, and
Social Health from the Patient-Reported Outcomes Measurement Information System (PROMIS)
after a four-week Occupational Therapy Health and Wellness Program from initial pretest
to posttest?
2. What changes occur in community-dwelling cancer survivors in self-perceived occupational
performance and satisfaction from the Canadian Occupational Performance Measure (COPM)
after a four-week Occupational Therapy Health and Wellness Program from initial pretest
to posttest?
3. What changes occur in community-dwelling cancer survivors in fatigue from the
Multidimensional Assessment of Fatigue Scale (MAF) after a four-week Occupational
Therapy Health and Wellness Program from initial pretest to posttest?
4. What changes occur in community-dwelling cancer survivors in sleep quality from the
Pittsburgh Sleep Quality Index (PSQI) after a four-week Occupational Therapy Health and
Wellness Program from initial pretest to posttest? It is hypothesized that there will be
improvements in participants self-perceived occupational performance and satisfaction,
fatigue levels, sleep quality, as well their mental, physical, and social quality of
life after participation in a four-week OT Health and Wellness Program. This study will
explore occupational therapy health and wellness cancer programming in a new service
setting of the community. It additionally will integrate innovative occupational therapy
community cancer programming looking at called for participation outcomes.
METHODS This quasi-experimental study will use a single group pretest-posttest study design
to explore the effects of a four-week Occupational Therapy Health and Wellness Program on
physical, mental, and social health (PROMIS), fatigue levels (MAF), Sleep quality (PSQI), and
self-perceived occupational performance and satisfaction (COPM) of community-dwelling cancer
survivors.
Participants This study defines cancer survivor as any person who has been diagnosed with
cancer from the time of diagnosis through the remainder of their life. Therefore, cancer
survivors will be included irrespective of their phase of survivorship (i.e. actively
receiving treatment, remission etc.).
An a priori power analysis using G*Power 3.1 was performed for a dependent-sample t test with
the following parameters: two-tailed test, power of .80, a Type I error (α) of .05, and a
medium effect size (d = .50). A minimum required sample size of 34 was determined. Taking
into account attrition rate (25%), a target sample size is set for 43. Using results reported
in a similar study of cancer survivors with an activity-based one week health program using
the COPM, an effect size was calculated at .53 so the minimum sample size would be 30).
Data collected will be de-identified by using a participant code (first three letters of the
participant's mother's first name and the last three digits of the participant's phone
number). Participant IP addresses will not be collected in Qualtrics. A list of participant
codes and their corresponding phone numbers will be stored on an encrypted google drive with
access for investigators only in order to make reminder phone calls for meeting times. The
study survey can be found at: https://uindy.co1.qualtrics.com/jfe/form/SV_56XfqHqrkLFYtNj
Procedures Recruitment. Survivors that are actively participating in programming at Cancer
Support Communities Central Indiana location as well as their satellite facilities (Community
Hospital, IU Health Simon Cancer Center, St. Vincent Cancer Care, and Hendricks Regional
Health), and CSC community network partners (Little Red Door, Pink Ribbon etc.) will receive
an informative flyer about the program. The program flyers will be posted at CSC and their
satellite facilities as well as emailed to other community network partners for distribution.
The OT Health and Wellness Program information will also be placed on CSC's programming
schedule. Programming recruitment will also be through word from the investigators to their
professional networks.
Screening. When a survivor calls to inquire about the OT programming, investigators will
check if their results from the CSC Distress Screening Tool indicate the need for OT
services. Those survivors that have indicated concerns of great severity on Cancer Support
Community (CSC) Distress Screening Tool (Likert Items: very serious, serious, and moderately
serious) in OT service provision areas related to finding meaning and purpose in life,
disruptions in school/work/home life, fatigue, and sleep problems will be included in the
study. This screening tool will be utilized to determine if participants are in need of the
four-week OT Health and Wellness Program services and this data will be retained for the
study.
Informed consent. Informed consent will happen at the survivor's first appointment with
either the primary investigator or one of the co-investigators. Informed consent will be
reviewed by one of the investigators and potential participants will indicate voluntary
consent on Qualtrics. If the participants indicates voluntary consent to participate by
continuing in Qualtrics, they will proceed into the COPM questionnaire. If the participant
does not consent, it will take them out of Qualtrics. No data will be collected on those that
do not provide voluntary consent.
Intervention. The OT Health and Wellness Program will have four weeks of education and
individual integration intervention modules. One of the investigators will lead each of these
weekly modules or students in the UIndy OTD program enrolled in OTD 620 Cancer Survivorship
elective course will run the modules under the direct supervision of the Principal
Investigator. Students will be trained to provide the standardized educational module for
each topic area and will not be interacting with any study data. Each module will have an
identified theme and information provided in each group will be education to topic, evidence
based literature on intervention strategies, lifestyle, or environmental modifications that
improve performance of daily activities that will last approximately 45 minutes. After, group
sharing of ideas and individual identification of weekly goals for integration of 1-3
targeted interventions will occur and last approximately 30-45 minutes). The program will
take place at CSC or one of their satellite facilities previously listed.
Data Analysis. Descriptive statistics will be used to describe the baseline and
post-intervention characteristics of the sample. Nominal data will be presented as
frequencies and percentages, while interval and ratio data will be reported as means and
standard deviations or medians and interquartile ranges, dependent on whether the data are
normally distributed. To determine if there is a significant difference in scores from
pre-intervention to post-intervention, scores will compared using a paired t test, if the
data are normally distributed, or the non-parametric Wilcoxon signed-ranks test if the data
are not normally distributed. Normality will be determined using the Shapiro Wilk test. Data
will be analyzed using IBM SPSS Statistics for Windows, Version 25.0. All comparisons will be
two-tailed and a significance level of less than .05 will be considered statistically
significant.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|